AOX4 Inhibitors are a specialized class of chemical compounds designed to specifically target and inhibit the activity of the AOX4 enzyme, which is a member of the aldehyde oxidase family. AOX4, like other aldehyde oxidases, plays a crucial role in the metabolism of a wide range of substrates, including aldehydes, aromatic heterocycles, and nitrogen-containing compounds. The enzyme catalyzes the oxidation of these substrates, converting them into their corresponding carboxylic acids while simultaneously reducing molecular oxygen to hydrogen peroxide. This oxidative process is essential in various metabolic pathways, particularly in the detoxification and biotransformation of endogenous and exogenous compounds. AOX4 Inhibitors function by binding to the active site of the AOX4 enzyme, where they block the enzyme's ability to interact with its natural substrates or interfere with the electron transfer process that is essential for the enzyme's catalytic activity.
The chemical structure and properties of AOX4 Inhibitors are carefully designed to ensure high specificity and efficacy in targeting the AOX4 enzyme. These inhibitors typically mimic the structure of the enzyme's natural substrates, allowing them to fit precisely within the active site. This competitive binding prevents the natural substrates from accessing the catalytic site, effectively inhibiting the enzyme's function. Additionally, AOX4 Inhibitors may contain functional groups that interact with key residues in the enzyme's active site, such as molybdenum or iron-sulfur clusters, which are critical for the enzyme's redox activity. These interactions can be covalent or non-covalent, depending on the design of the inhibitor, and are intended to stabilize the inhibitor within the active site, thereby enhancing its inhibitory effect. The solubility, stability, and bioavailability of these inhibitors are optimized to ensure they can effectively reach and inhibit AOX4 in its native cellular environment. The kinetics of binding, including how rapidly the inhibitor associates with and dissociates from AOX4, play a crucial role in determining the potency and duration of inhibition. By understanding the interactions between AOX4 Inhibitors and the enzyme, researchers can gain valuable insights into the metabolic roles of AOX4 and the broader implications of its inhibition in cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Vitamin K3 | 58-27-5 | sc-205990B sc-205990 sc-205990A sc-205990C sc-205990D | 5 g 10 g 25 g 100 g 500 g | $26.00 $36.00 $47.00 $136.00 $455.00 | 3 | |
Menadione inhibits aldehyde oxidase 4 by competing with the natural substrates for binding at the active site, reducing the enzyme's ability to catalyze oxidation reactions. | ||||||
Raloxifene | 84449-90-1 | sc-476458 | 1 g | $802.00 | 3 | |
Raloxifene binds to the active site of aldehyde oxidase 4, acting as a competitive inhibitor, thereby preventing the enzyme from oxidizing its physiological substrates. | ||||||
Indomethacin | 53-86-1 | sc-200503 sc-200503A | 1 g 5 g | $29.00 $38.00 | 18 | |
Indomethacin interacts with the molybdenum cofactor of aldehyde oxidase 4, impairing the enzyme's catalytic function which is essential for the oxidation of substrates. | ||||||
Methimazole | 60-56-0 | sc-205747 sc-205747A | 10 g 25 g | $70.00 $112.00 | 4 | |
Methimazole functions as an inhibitor by binding to the molybdenum center of aldehyde oxidase 4, essential for its enzymatic activity, thus inhibiting the oxidation process. | ||||||
Thiabendazole | 148-79-8 | sc-204913 sc-204913A sc-204913B sc-204913C sc-204913D | 10 g 100 g 250 g 500 g 1 kg | $32.00 $84.00 $183.00 $312.00 $572.00 | 5 | |
Thiabendazole inhibits aldehyde oxidase 4 by binding to its active site, which prevents the enzyme from interacting with and oxidizing its natural substrates. | ||||||
Clozapine | 5786-21-0 | sc-200402 sc-200402A sc-200402B sc-200402C | 50 mg 500 mg 5 g 10 g | $69.00 $364.00 $2500.00 $4100.00 | 11 | |
Clozapine acts as a substrate for aldehyde oxidase 4 but is poorly metabolized, thus effectively inhibiting the oxidation of physiological substrates by occupying the active site. | ||||||